Mitsubishi UFJ Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$103K Buy
6,052
+3,414
+129% +$58.4K ﹤0.01% 1029
2025
Q1
$168K Buy
2,638
+209
+9% +$13.3K ﹤0.01% 972
2024
Q4
$307K Buy
2,429
+243
+11% +$30.7K ﹤0.01% 927
2024
Q3
$273K Sell
2,186
-193
-8% -$24.1K ﹤0.01% 926
2024
Q2
$376K Sell
2,379
-599
-20% -$94.6K ﹤0.01% 891
2024
Q1
$386K Sell
2,978
-130
-4% -$16.8K ﹤0.01% 900
2023
Q4
$291K Buy
3,108
+1,227
+65% +$115K ﹤0.01% 973
2023
Q3
$228K Buy
1,881
+43
+2% +$5.21K ﹤0.01% 1008
2023
Q2
$210K Sell
1,838
-673
-27% -$77.1K ﹤0.01% 1033
2023
Q1
$346K Buy
2,511
+145
+6% +$20K ﹤0.01% 969
2022
Q4
$295K Sell
2,366
-1,271
-35% -$159K ﹤0.01% 980
2022
Q3
$402K Buy
3,637
+57
+2% +$6.3K ﹤0.01% 924
2022
Q2
$268K Sell
3,580
-356
-9% -$26.7K ﹤0.01% 1011
2022
Q1
$307K Buy
3,936
+425
+12% +$33.1K ﹤0.01% 995
2021
Q4
$317K Sell
3,511
-467
-12% -$42.2K ﹤0.01% 1000
2021
Q3
$368K Buy
3,978
+102
+3% +$9.44K ﹤0.01% 983
2021
Q2
$301K Sell
3,876
-14,495
-79% -$1.13M ﹤0.01% 1037
2021
Q1
$1.37M Buy
18,371
+2,182
+13% +$163K 0.01% 764
2020
Q4
$2.76M Buy
16,189
+1,318
+9% +$225K 0.02% 584
2020
Q3
$2.09M Buy
14,871
+2,045
+16% +$287K 0.02% 572
2020
Q2
$2.06M Buy
12,826
+928
+8% +$149K 0.02% 536
2020
Q1
$1.16M Sell
11,898
-1,803
-13% -$176K 0.02% 589
2019
Q4
$1.78M Buy
13,701
+1,468
+12% +$191K 0.02% 569
2019
Q3
$921K Buy
12,233
+11,238
+1,129% +$846K 0.02% 641
2019
Q2
$151K Sell
995
-389
-28% -$59K ﹤0.01% 864
2019
Q1
$165K Buy
1,384
+165
+14% +$19.7K ﹤0.01% 817
2018
Q4
$130K Sell
1,219
-264
-18% -$28.2K ﹤0.01% 809
2018
Q3
$240K Buy
+1,483
New +$240K ﹤0.01% 754
2013
Q3
Sell
-6,800
Closed -$259K 832
2013
Q2
$259K Buy
+6,800
New +$259K 0.01% 662